Literature DB >> 1882073

[Cerebral manifestations of Erdheim-Chester disease].

C Kujat1, B Junk, M Hermes, J Martin, W Dewes.   

Abstract

Cerebral manifestations of Erdheim-Chester disease are variable, giving a picture like that of multiple sclerosis. White matter lesions are located mainly in cerebellum and pons and lipid granulomas in the meninges. An asymptomatic lesion in the choroid plexus, with prolonged uptake of Gd-DTPA is described for the first time.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1882073

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  5 in total

Review 1.  Cerebral Erdheim-Chester disease: case report and review of the literature.

Authors:  Stefan Weidauer; Sebastian von Stuckrad-Barre; Edgar Dettmann; Friedhelm E Zanella; Heinrich Lanfermann
Journal:  Neuroradiology       Date:  2003-02-21       Impact factor: 2.804

Review 2.  Neurological manifestations and neuroradiological presentation of Erdheim-Chester disease: report of 6 cases and systematic review of the literature.

Authors:  Florence Lachenal; François Cotton; Hélène Desmurs-Clavel; Julien Haroche; Hervé Taillia; Nadine Magy; Mohamed Hamidou; Juan Salvatierra; Jean-Charles Piette; Denis Vital-Durand; Hugues Rousset
Journal:  J Neurol       Date:  2006-10-24       Impact factor: 4.849

3.  Erdheim-chester disease mimicking multiple meningiomas syndrome.

Authors:  Mahlon D Johnson; Joseph P Aulino; Madan Jagasia; Louise A Mawn
Journal:  AJNR Am J Neuroradiol       Date:  2004-01       Impact factor: 3.825

4.  Improvement of Erdheim-Chester disease in two patients by sequential treatment with vinblastine and mycophenolate mofetil.

Authors:  Michael C Jendro; Henning Zeidler; Herbert Rosenthal; Hermann Haller; Anke Schwarz
Journal:  Clin Rheumatol       Date:  2003-11-07       Impact factor: 2.980

5.  A case of cerebral erdheim-chester disease with progressive cerebellar syndrome.

Authors:  Sang-Jun Na; Kee Ook Lee; Jung Eun Kim; Yong-Duk Kim
Journal:  J Clin Neurol       Date:  2008-03-20       Impact factor: 3.077

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.